FoxG1/BNIP3 axis promotes mitophagy and blunts cisplatin resistance in osteosarcoma
Cancer Science · 2024
DOI: 10.1111/cas.16242 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2024. Verfasst von Baolong Pan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Health Examination Center, Sixth Affiliated Hospital of Kunming Medical University, Yuxi, Yunnan, China. Hauptthemen laut MEDLINE: Osteosarcoma, Mitophagy, Cisplatin, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cisplatin (CDDP) is a commonly used chemotherapeutic for osteosarcoma (OS) patients, and drug resistance remains as a major hurdle to undermine the treatment outcome. Here, we investigated the potential involvement of FoxG1 and BNIP3 in CDDP resistance of OS cells. FoxG1 and BNIP3 expression levels were detected in the CDDP‐sensitive and CDDP‐resistant OS tumors and cell lines. Mitophagy was observed through transmission electron microscope analysis. The sensitivity to CDDP in OS cells upon FoxG1 overexpression was examined in cell and animal models. We found that FoxG1 and BNIP3 showed significant downregulation in the CDDP‐resistant OS tumor samples and cell lines. CDDP‐resistant OS tumor specimens and cells displayed impaired mitophagy. FoxG1 overexpression promoted BNIP3 expression, enhanced mitophagy in CDDP‐resistant OS cells, and resensitized the resistant cells to CDDP treatment in vitro and in vivo. Our data highlighted the role of the FoxG1/BNIP3 axis in regulating mitophagy and dictating CDDP resistance in OS cells, suggesting targeting FoxG1/BNIP3‐dependent mitophagy as a potential strategy to overcome CDDP resistance in OS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Examination Center, Sixth Affiliated Hospital of Kunming Medical University, Yuxi, Yunnan, China.
- Department of Neuroendocrine, Yuxi Children's Hospital, Yuxi, Yunnan, China.
- Department of Pharmacy, Kunming Children's Hospital, Kunming, Yunnan, China.
- Department of Asset Management, Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
- College of Basic Medical Sciences, Naval Medical University, Shanghai, China.
- Second Department of Orthopedics, Third Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
ORCID-Profile: Baolong Pan
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Pan, B., Li, Y., Han, H., Zhang, L., Hu, X., Pan, Y., & Peng, Z. (2024). FoxG1/BNIP3 axis promotes mitophagy and blunts cisplatin resistance in osteosarcoma. Cancer Science. https://doi.org/10.1111/cas.16242
Vancouver
Pan B, Li Y, Han H, Zhang L, Hu X, Pan Y, et al. FoxG1/BNIP3 axis promotes mitophagy and blunts cisplatin resistance in osteosarcoma. Cancer Science. 2024. doi:10.1111/cas.16242
BibTeX
@article{Pan2024,
author = {Pan, Baolong and Li, Yan and Han, Huiyun and Zhang, Lu and Hu, Xuemei and Pan, Yanyu and Peng, Zhuohui},
title = {FoxG1/BNIP3 axis promotes mitophagy and blunts cisplatin resistance in osteosarcoma},
journal = {Cancer Science},
year = {2024},
doi = {10.1111/cas.16242}
}
EUVIMED